Kyle Duncan (judge) & GenBioPro
1 shared events · Importance 3 · Last updated May 03, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
NewsDesk Dashboard
Judge Kyle Duncan authored a federal appeals court ruling restricting mail-order access to mifepristone, directly impacting the business of generic manufacturer GenBioPro.
Regulatory
Kyle Duncan (judge): Kyle Duncan (judge), a Trump appointee, wrote for the United States — United States Court of Appeals for the Third Circuit, stating that the United States — Food and Drug Administration's relaxation of Mifepristone's guardrails likely lacked scientific basis.
GenBioPro: GenBioPro, a generic Mifepristone manufacturer, stated that the court's decision ignores the United States — Food and Drug Administration's science and decades of safe use of the drug.
May 01, 2026 · 78 articles
NEWSDESK
Explore this relationship live
Track how Kyle Duncan (judge) and GenBioPro interact across events, view sentiment trends, and discover connected entities.
Open Dashboard